Earnings Results: This insulin-pump company’s stock is plunging, and executives say it’s because diabetics in U.S. can’t afford the technology

Tandem Diabetes Care Inc. shares plummeted more than 20% after the company reported earnings Wednesday, continuing a decline that has already cost the company two-thirds of its market value this year.

Advertisements

Read More

Previous post What the election in Brazil can teach America
Next post Congress can stop credit card companies from squeezing small business